Product Information

ARMODAFINIL 150 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.7954 per EA under NDC 00093309256. Its NADAC has been published 502 times since Jan 11, 2017.

FDA first approved this application on Jun 15, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ARMODAFINIL 150 MG TABLET

Armodafinil
$0.7954per EA
DEA Schedule CIV

Strength

150 mg/1

NDC

00093309256

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ARMODAFINIL

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021875

FDA Approved

6/15/2007

TE Code

AB

On Market Since

11/29/2016

Price Statistics

The NADAC for ARMODAFINIL 150 MG TABLET has been published 502 times since Jan 11, 2017, and over the history we have for it it has declined 95.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7954 per EA
All-time high$17.0365 (Jan 11, 2017)
All-time low$0.5352 (Nov 20, 2024)
52-week high$0.8371
52-week low$0.7517
Median price$0.8627
Average price$1.1738
Largest weekly change-87.3% (Feb 22, 2017)
Weeks tracked502
Tracking sinceJan 11, 2017

Price History

1W

-0.3%

1M

-0.3%

3M

+1.6%

6M

+0.7%

1Y

+5.8%

3Y

-3.4%

5Y

-3.4%

All

-95.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of ARMODAFINIL 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ARMODAFINIL 150 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.7954 per EA (NDC 00093309256), effective Aug 19, 2026.

How has the price of ARMODAFINIL 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for ARMODAFINIL 150 MG TABLET has declined 95.3%. It has been tracked across 502 weekly CMS publications since Jan 11, 2017.

What are the highest and lowest recorded NADAC prices for ARMODAFINIL 150 MG TABLET?

Since Jan 11, 2017, the NADAC for ARMODAFINIL 150 MG TABLET has ranged from a low of $0.5352 (Nov 20, 2024) to a high of $17.0365 (Jan 11, 2017), with a median of $0.8627 per EA.

Are there cheaper alternatives to ARMODAFINIL 150 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARMODAFINIL 150 MG TABLET, is $0.7517 per EA — about 5% below ARMODAFINIL 150 MG TABLET.

Who manufactures ARMODAFINIL 150 MG TABLET?

ARMODAFINIL 150 MG TABLET (NDC 00093309256) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.